Childhood vaccination schedule: Difference between revisions

Revision as of 19:38, 11 April 2017

Template:Vaccination schedule Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Childhood vaccination schedule

The following table summarizes the vaccination schedule for Adolescents Aged 18 Years or Younger based on CDC 2017 recommendation.

Vaccine	Birth	1 mo	2 mos	4 mos	6 mos	12 mos	15 mos	2-3 yrs	4-6 yrs	7-10 yrs	11-12 yrs	16 yrs
Hepatitis B¹ (Hep B)	1st dose	2nd dose			3rd dose
Rotavirus² (RV) RV1 (2-dose series); RV5 (3-dose series)			1st dose	2nd dose	See footnote 2
Diphtheria, tetanus, & acellular pertussis³ (DTaP: <7 yrs)			1st dose	2nd dose	3rd dose		4th dose		5th dose
Haemophilus influenzae type b⁴ (Hib)			1st dose	2nd dose	See footnote 4	3rd or 4th dose, See footnote 4
Pneumococcal conjugate⁵ (PCV13)			1st dose	2nd dose	3rd dose	4th dose
Inactivated poliovirus⁶ (IPV: <18 yrs)			1st dose	2nd dose	3rd dose				4th dose
Influenza⁷ (IIV)					Annual vaccination (IIV) 1 or 2 doses						Annual vaccination (IIV) 1 dose only
Measles, mumps, rubella⁸ (MMR)					See footnote 8	1st dose			2nd dose
Varicella⁹ (VAR)						1st dose			2nd dose
Hepatitis A¹⁰ (Hep A)						2-dose series, See footnote 10
Meningococcal¹¹ (Hib-MenCY >6 weeks; MenACWY-D >9 mos; MenACWY-CRM ≥2 mos)			See footnote 11								1st dose	2nd dose
Tetanus, diphtheria, & acellular pertussis¹² (Tdap: >7 yrs)											Tdap
Human papillomavirus¹³ (HPV)												See footnote 13
Meningococcal B¹¹										See footnote 11
Pneumococcal polysaccharide⁵ (PPSV23)								See footnote 5

Sources and notes

External links

National Center for Immunization and Respiratory Diseases. "CDC National Immunization Program". CDC. Retrieved 2006-09-18.
"MMR vaccine and the autism epidemic: In a compulsory inoculation program, it is the responsibility of the developers, promoters and enforcers to prove safety and efficacy". MMR vaccine and the autism epidemic. InformedChoice.info. Retrieved 2006-09-18.
National Health Service of UK. "UK Immunisation Schedule and Information". NHS. Retrieved 2006-11-03.

Template:Vaccines

de:Impfkalender id:Jadwal imunisasi

Template:WikiDoc Sources

@@ Line 28: / Line 28: @@
 ! align="center" style="background:#4479BA; color: #FFFFFF;" |17-18 yrs
 |-
-|align="center" style="background:#DCDCDC;"|Hepatitis B1 (HepB)
+|align="center" style="background:#DCDCDC;"|Hepatitis B<sup>1</sup> (Hep B)
 |style="background: #F0E68C; padding: 5px text-align:center" |1st dose
 | colspan="2" style="background: #F0E68C; padding: 5px text-align:center" |2nd dose
@@ Line 35: / Line 35: @@
 | colspan="8" style="background: #AFEEEE; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Rotavirus2 (RV) RV1 (2-dose series);
+|align="center" style="background:#DCDCDC;"|Rotavirus<sup>2</sup> (RV) RV1 (2-dose series);
 RV5 (3-dose series)
 |style="background:#F8F8FF; |
@@ Line 55: / Line 55: @@
 |style="background:#F8F8FF; |
 |-
-|align="center" style="background:#DCDCDC;"|Diphtheria, tetanus, & acellular pertussis3
+|align="center" style="background:#DCDCDC;"|Diphtheria, tetanus, & acellular pertussis<sup>3</sup>
 (DTaP: <7 yrs)
 |style="background:#F8F8FF; |
@@ Line 72: / Line 72: @@
 |style="background:#F8F8FF; |
 |-
-|align="center" style="background:#DCDCDC;"|Haemophilus influenzae type b4 (Hib)
+|align="center" style="background:#DCDCDC;"|Haemophilus influenzae type b<sup>4</sup> (Hib)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 84: / Line 84: @@
 | colspan="5" style="background: #DCDCDC; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Pneumococcal conjugate5 (PCV13)
+|align="center" style="background:#DCDCDC;"|Pneumococcal conjugate<sup>5</sup> (PCV13)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 95: / Line 95: @@
 | colspan="5" style="background: #DCDCDC; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Inactivated poliovirus6 (IPV: <18 yrs)
+|align="center" style="background:#DCDCDC;"|Inactivated poliovirus<sup>6</sup> (IPV: <18 yrs)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 105: / Line 105: @@
 | colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Influenza7 (IIV)
+|align="center" style="background:#DCDCDC;"|Influenza<sup>7</sup> (IIV)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 113: / Line 113: @@
 | colspan="4" align="center" style="background: #F0E68C; padding: 5px text-align:center" |Annual vaccination (IIV) 1 dose only
 |-
-|align="center" style="background:#DCDCDC;"|Measles, mumps, rubella8 (MMR)
+|align="center" style="background:#DCDCDC;"|Measles, mumps, rubella<sup>8</sup> (MMR)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 124: / Line 124: @@
 | colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Varicella9 (VAR)
+|align="center" style="background:#DCDCDC;"|Varicella<sup>9</sup> (VAR)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 136: / Line 136: @@
 | colspan="5" style="background: #AFEEEE; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Hepatitis A1 0 (HepA)
+|align="center" style="background:#DCDCDC;"|Hepatitis A<sup>10</sup> (Hep A)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 152: / Line 152: @@
 |style="background: #AFEEEE; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Meningococcal1 1 (Hib-MenCY >6 weeks;
+|align="center" style="background:#DCDCDC;"|Meningococcal<sup>11</sup> (Hib-MenCY >6 weeks;
 MenACWY-D >9 mos; MenACWY-CRM ≥2 mos)
 |style="background:#F8F8FF; |
@@ Line 162: / Line 162: @@
 |style="background: #AFEEEE; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Tetanus, diphtheria, & acellular pertussis12 (Tdap: >7 yrs)
+|align="center" style="background:#DCDCDC;"|Tetanus, diphtheria, & acellular pertussis<sup>12</sup> (Tdap: >7 yrs)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 179: / Line 179: @@
 | colspan="3" style="background: #AFEEEE; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Human papillomavirus1 3 (HPV)
+|align="center" style="background:#DCDCDC;"|Human papillomavirus<sup>13</sup> (HPV)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 196: / Line 196: @@
 | colspan="3" colspan="3" style="background: #AFEEEE; padding: 5px text-align:center" |
 |-
-|align="center" style="background:#DCDCDC;"|Meningococcal B1 1
+|align="center" style="background:#DCDCDC;"|Meningococcal B<sup>11</sup>
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |
@@ Line 211: / Line 211: @@
 | colspan="5" align="center" style="background: #DCDCDC; padding: 5px text-align:center" |See footnote 11
 |-
-|align="center" style="background:#DCDCDC;"|Pneumococcal polysaccharide5 (PPSV23)
+|align="center" style="background:#DCDCDC;"|Pneumococcal polysaccharide<sup>5</sup> (PPSV23)
 |style="background:#F8F8FF; |
 |style="background:#F8F8FF; |

Childhood vaccination schedule: Difference between revisions

Revision as of 19:38, 11 April 2017

Overview

Childhood vaccination schedule

See also

Sources and notes

External links

Navigation menu